Press Releases May 13, 2026 08:30 AM

Bath & Body Works To Report First Quarter Results On May 27, 2026

Bath & Body Works announces Q1 2026 earnings release date and upcoming investor call.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
BBWI

Bath & Body Works, Inc. is set to release its Q1 2026 financial results on May 27, 2026, before market open. The company will hold a conference call with its CEO and CFO to discuss the results and provide a business update. Supplemental materials and webcast will be available through the company's investor relations website.

Bath & Body Works To Report First Quarter Results On May 27, 2026
BBWI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bath & Body Works will report Q1 2026 results on May 27, 2026, before market open.
  • A conference call with CEO and CFO will provide insights into financial results and business outlook.
  • The company operates over 1,900 stores in the U.S. and Canada, plus 500+ international locations, and sells through online channels including Amazon.

COLUMBUS, Ohio, May 13, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its first quarter 2026 financial results before market open on Wednesday, May 27, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company’s website at bbwinc.com.

Investors and analysts interested in participating in the conference call are invited to dial 877-407-9219 (domestic) or 412-652-1274 (international). A telephone replay of the conference call can be accessed by dialing 877-660-6853 (domestic) or 201-612-7415 (international) and entering access code 13760165.

To listen to the audio webcast, please visit the events and presentations page in the Investors section of the company’s website at bbwinc.com. The webcast replay will be available approximately three hours following the live call and archived for 90 days.

ABOUT BATH & BODY WORKS:

Bath & Body Works is a global leader in personal care and home fragrance, driven by the belief that everybody deserves to feel good.

The brand’s beloved and iconic scents are expertly crafted for exceptional performance and a luxury fragrance experience. Formulated with thoughtfully chosen ingredients, Bath & Body Works’ body care products are available in multiple forms including fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and more. The brand’s famous 3-wick candles are made with rich, high quality fragrance oils layered throughout a premium soy wax base, for up to 45 hours of room-filling fragrance.

Consumers can shop Bath & Body Works anytime and anywhere they choose, from welcoming, in-store experiences at more than 1,900 stores in the U.S. and Canada, 500-plus international locations, online at bathandbodyworks.com and on Amazon.

For further information, please contact:

Bath & Body Works:
Investor Relations
Luke Long
[email protected]

Media Relations
Emmy Beach
[email protected]


Risks

  • Market reception of Q1 2026 results may affect stock performance depending on revenue and profit figures.
  • Consumer demand variability in personal care and fragrance markets may impact business outlook.
  • Potential operational risks tied to retail store performance and supply chain factors.

More from Press Releases

Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026 Jun 26, 2026 XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service Jun 26, 2026 Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering Jun 26, 2026 dLocal added to membership of US small-cap Russell 2000® Index Jun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance Jun 26, 2026